By Brazil Stock Guide – Oncoclínicas (ONCO3.SA) has sold the Hospital UMC in Uberlândia (MG) to its founder, Alexandre de Menezes Rodrigues, in a transaction valued at approximately R$ 160 million, including debt assumption. This marks the second sale of non-oncology assets by the company, following a similar deal in Rio de Janeiro with the acquisition of another hospital by Hapvida (HAPV3.SA) earlier this week.
The Hospital UMC was acquired by Oncoclínicas in 2021 for R$ 400 million, when the company purchased 84% of the business, which includes a general hospital, imaging services, and a cardiology unit. Despite the hospital’s 230 beds, it struggled to generate synergies with Oncoclínicas’ core oncology business, leading to its sale.
The sale is part of Oncoclínicas’ broader strategy to streamline operations and reduce its leverage, which stood at 4.4 times EBITDA in Q2 2025. The company is divesting from non-oncology assets, including three other hospitals in Rio de Janeiro, Belo Horizonte, and Uberlândia, which have failed to achieve financial targets.
In parallel, Oncoclínicas is also in discussions to transfer control of its Saudi Arabia operation to the local partner, Al Faisaliah Group. The Saudi venture, which focuses on expanding cancer treatment clinics across the region, was initially co-owned 50/50 between Oncoclínicas and Al Faisaliah.
This restructuring aims to strengthen Oncoclínicas’ position in the oncology sector while reducing financial strain and refocusing on its core market.
Source: Valor Econômico
Leave a Reply